Company Filing History:
Years Active: 2019
Title: The Innovations of Shaoxuan Zhu
Introduction
Shaoxuan Zhu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating respiratory diseases. His work has the potential to impact the lives of many individuals suffering from chronic conditions.
Latest Patents
Shaoxuan Zhu holds a patent for an S-(carboxymethyl)-cysteine pharmaceutical compound and its preparation method and use. This patent discloses an S-(carboxymethyl)-cysteine pharmaceutical compound, along with a preparation method and its applications. The invention also includes an S-(carboxymethyl)-D-cysteine ammonium salt monohydrate, which is utilized in the preparation of medicines for preventing and treating respiratory system diseases, such as chronic obstructive pulmonary disease (COPD). The compounds developed can reduce airway resistance and the production of oxides in rat COPD models, increase antioxidant levels, and alleviate damage caused by oxides and inflammatory mediators to the lungs.
Career Highlights
Throughout his career, Shaoxuan Zhu has worked with prominent organizations, including Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. and Baiyunshan Pharmaceutical General Factory. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Shaoxuan Zhu has collaborated with notable colleagues, including Mao Chen and Ping Wan. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.
Conclusion
Shaoxuan Zhu's contributions to the field of pharmaceuticals, particularly through his patent for S-(carboxymethyl)-cysteine, highlight his dedication to improving respiratory health. His work exemplifies the importance of innovation in medicine and its potential to enhance the quality of life for many individuals.